Education
About Us
Working with TipRanks
Follow Us
Hisamitsu Pharmaceutical Co Inc (HTSUF)
OTHER OTC:HTSUF
RESEARCH TOOLSreports
Total Valuation
Hisamitsu Pharmaceutical Co has a market cap or net worth of $2.08B. The enterprise value is $198.51B.
Market Cap$2.08B
Enterprise Value$198.51B
Share Statistics
Hisamitsu Pharmaceutical Co has 75,164,894 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding75,164,894
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Hisamitsu Pharmaceutical Co’s return on equity (ROE) is 0.08 and return on invested capital (ROIC) is 4.94%.
Return on Equity (ROE)0.08
Return on Assets (ROA)0.06
Return on Invested Capital (ROIC)4.94%
Return on Capital Employed (ROCE)0.06
Revenue Per Employee56.54M
Profits Per Employee10.40M
Employee Count2,759
Asset Turnover0.45
Inventory Turnover2.89
Valuation Ratios
The current PE Ratio of Hisamitsu Pharmaceutical Co is 16.4. Hisamitsu Pharmaceutical Co’s PEG ratio is ―.
PE Ratio16.4
PS Ratio―
PB Ratio―
Price to Fair Value0.98
Price to FCF―
Price to Operating Cash Flow0.00
PEG Ratio―
Income Statement
In the last 12 months, Hisamitsu Pharmaceutical Co had revenue of 156.01B and earned 21.76B in profits. Earnings per share was 295.57.
Revenue156.01B
Gross Profit91.20B
Operating Income18.89B
Pretax Income28.69B
Net Income21.76B
EBITDA35.05B
Earnings Per Share (EPS)295.57
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
Hisamitsu Pharmaceutical Co pays an annual dividend of $0.416, resulting in a dividend yield of 2.43%
Dividend Per Share$0.416
Dividend Yield2.43%
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.17
52-Week Price Change4.96%
50-Day Moving Average28.11
200-Day Moving Average28.41
Relative Strength Index (RSI)45.75
Average Volume (3m)3.00
Important Dates
Hisamitsu Pharmaceutical Co upcoming earnings date is Jan 8, 2026, TBA (Confirmed).
Last Earnings DateJan 9, 2025
Next Earnings DateJan 8, 2026
Ex-Dividend DateFeb 27, 2026
Financial Position
Hisamitsu Pharmaceutical Co as a current ratio of 4.32, with Debt / Equity ratio of 1.39%
Current Ratio4.32
Quick Ratio3.84
Debt to Market Cap0.01
Net Debt to EBITDA-3.16
Interest Coverage Ratio821.52
Taxes
In the past 12 months, Hisamitsu Pharmaceutical Co has paid 6.38B in taxes.
Income Tax6.38B
Effective Tax Rate0.22
Enterprise Valuation
Hisamitsu Pharmaceutical Co EV to EBITDA ratio is 4.61, with an EV/FCF ratio of 32.38.
EV to Sales1.04
EV to EBITDA4.61
EV to Free Cash Flow32.38
EV to Operating Cash Flow8.61
Balance Sheet
Hisamitsu Pharmaceutical Co has $129.12B in cash and marketable securities with $3.86B in debt, giving a net cash position of $125.26B billion.
Cash & Marketable Securities$129.12B
Total Debt$3.86B
Net Cash$125.26B
Net Cash Per Share$1.67K
Tangible Book Value Per Share$3.71K
Margins
Gross margin is 58.46%, with operating margin of 12.11%, and net profit margin of 13.95%.
Gross Margin58.46%
Operating Margin12.11%
Pretax Margin18.39%
Net Profit Margin13.95%
EBITDA Margin22.46%
EBIT Margin18.40%
Analyst Forecast
The average price target for Hisamitsu Pharmaceutical Co is $32.07, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$32.07
Price Target Upside12.29% Upside
Analyst ConsensusModerate Buy
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―